Effect of Sitagliptin on Plaques and Cardiac Function following ACS

Not Applicable

Recruiting

• Conditions: Acute Coronary Syndrome end Type 2 Diabetes Mellitus

• Registration Number: JPRN-UMIN000007900
• Lead Sponsor: ESPECIAL-ACS office

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-05-07
• Study Completion: 2013-12-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 46

Inclusion Criteria

Not provided

Exclusion Criteria

1)diseased bypass graft 2)Patients who have plaque in a non-culprit site on the PCI vessel and might undergo PCI during the treatment period. 3)Patients receiving DPP4 inhibitor drugs and GLP-1 and high dose SU drugs at admission 4)Patients receiving more than 3 anti-diabetic drugs 5)Patients with acute congestive heart failure 6)Patients with ketoacidosis and diabetic coma within 6 months 7)Severe infection, Pre-operative and post-operative state, and severe trauma 8)Pregnant women, women suspected of being pregnant, or lactating women 9)Patients with severe renal disorders or undergoing dialysis 10)Patients with active malignant tumor 11)Patients with any allergy to DPP4 inhibitor 12)Patients who are ineligible in the opinion of the investigator.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
percent change in coronary plaque volume